<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="53094">Imidazoline</z:chebi> compounds have been considered for the treatment of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We have now investigated the effects of <z:chebi fb="1" ids="53094">imidazolines</z:chebi> on interleukin (IL)-1beta-induced beta-cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and the signal transduction pathways involved </plain></SENT>
<SENT sid="2" pm="."><plain>Inhibition of <z:chebi fb="0" ids="29108">Ca2+</z:chebi> influx into beta-cells by D-600, a blocker of voltage-gated L-type <z:chebi fb="0" ids="29108">Ca2+</z:chebi> channels, suppressed IL-1beta-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Our data show that calcineurin, <z:chebi fb="0" ids="29108">Ca2+</z:chebi>/calmodulin-dependent serine/threonine protein phosphatase 2B, is responsible for the effect of <z:chebi fb="0" ids="29108">Ca2+</z:chebi> on beta-cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>We also demonstrate that IL-1beta-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> correlates with expression of inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS) and the increase in intracellular production of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>An inhibitor of cGMP-dependent protein kinase (PKG), KT5823, suppressed IL-1beta-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, suggesting the involvement of a PKG-dependent pathway in the apoptotic process </plain></SENT>
<SENT sid="6" pm="."><plain>One of the major findings in this study is that <z:chebi fb="1" ids="53094">imidazoline</z:chebi> compounds RX871024 and efaroxan, suggested as prototypes of a new generation of drugs against type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, can protect against IL-1beta-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in pancreatic beta-cells, possibly by their inhibition of the expression of iNOS, a key element in the IL-1beta-induced apoptotic pathway in pancreatic beta-cells </plain></SENT>
<SENT sid="7" pm="."><plain>These data suggest that <z:chebi fb="1" ids="53094">imidazoline</z:chebi> compounds should be explored as a potential therapeutic agent for the treatment of both type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>